IntReALL HR and the benefits of adaptive design

by Holmes, Jane, Love, Sharon, Saha, Vaskar, von Stackelberg, Arend
Published 2015

Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergro...

by Biondi, Andrea, Schrappe, Martin, De Lorenzo, Paola, Castor, Anders, Lucchini, Giovanna, Gandemer, Virginie, Pieters, Rob, Stary, Jan, Escherich, Gabriele, Campbell, Myriam, Li, Chi-Kong, Vora, Ajay, Aricò, Maurizio, Röttgers, Silja, Saha, Vaskar, Valsecchi, Maria Grazia
Published 2012

5T4 oncofoetal antigen is expressed in high risk of relapse childhood pre-B acute lymphoblastic leukemia and is associated with a more invasive and chemotactic phenotype

by Castro, Fernanda V, McGinn, Owen J, Krishnan, Shekhar, Marinov, Georgi, Li, Jian, Rutkowski, Andrzej J, Elkord, Eyad, Burt, Debbie, Holland, Mark, Vaghjiani, Rasilaben, Gallego, Aurelia, Saha, Vaskar, Stern, Peter L
Published 2012

Stromal cell-mediated mitochondrial redox adaptation regulates drug resistance in childhood acute lymphoblastic leukemia

by Liu, Jizhong, Masurekar, Ashish, Johnson, Suzanne, Chakraborty, Sohini, Griffiths, John, Smith, Duncan, Alexander, Seema, Dempsey, Clare, Parker, Catriona, Harrison, Stephanie, Li, Yaoyong, Miller, Crispin, Di, Yujun, Ghosh, Zhumur, Krishnan, Shekhar, Saha, Vaskar
Published 2015

Outcome of Central Nervous System Relapses In Childhood Acute Lymphoblastic Leukaemia – Prospective Open Cohort Analyses of the ALLR3 Trial

by Masurekar, Ashish Narayan, Parker, Catriona A., Shanyinde, Milensu, Moorman, Anthony V., Hancock, Jeremy P., Sutton, Rosemary, Ancliff, Philip J., Morgan, Mary, Goulden, Nicholas J., Fraser, Chris, Hoogerbrugge, Peter M., Revesz, Tamas, Darbyshire, Philip J., Krishnan, Shekhar, Love, Sharon B., Saha, Vaskar
Published 2014